Gene · 2829
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Host Genetic Risk Factors Associated with COVID-19 Susceptibility and Severity in Vietnamese. | Genes (Basel) | 2022 | 36292769 | PubTator, text mining | PubMed |
| Use of Cannabis and Cannabinoids for Treatment of Cancer. | Cancers (Basel) | 2022 | 36291926 | PubTator, text mining | PubMed |
| Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance. | Cells | 2022 | 36291050 | PubTator, text mining | PubMed |
| Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. | Immunity | 2022 | 36288724 | PubTator, text mining | PubMed |
| A methodology for classifying tissue-specific metabolic and inflammatory receptor functions applied to subcutaneous and visceral adipose. | PLoS One | 2022 | 36282842 | PubTator, text mining | PubMed |
| Strategies to overcome DC dysregulation in the tumor microenvironment. | Front Immunol | 2022 | 36275666 | PubTator, text mining | PubMed |
| Mechanisms of CD40-dependent cDC1 licensing beyond costimulation. | Nat Immunol | 2022 | 36271147 | PubTator, text mining | PubMed |
| How cell migration helps immune sentinels. | Front Cell Dev Biol | 2022 | 36268510 | PubTator, text mining | PubMed |
| Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis. | J Oncol | 2022 | 36268282 | PubTator, text mining | PubMed |
| Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice. | Front Immunol | 2022 | 36263022 | PubTator, text mining | PubMed |
| Follow-up of young adult monozygotic twins after simultaneous critical coronavirus disease 2019: A case report. | Front Med (Lausanne) | 2022 | 36250103 | PubTator, text mining | PubMed |
| Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36248785 | PubTator, text mining | PubMed |
| The soldiers needed to be awakened: Tumor-infiltrating immune cells. | Front Genet | 2022 | 36246629 | PubTator, text mining | PubMed |
| Metabolic guidance and stress in tumors modulate antigen-presenting cells. | Oncogenesis | 2022 | 36244976 | PubTator, text mining | PubMed |
| Analysis of gene expression profiles to study malaria vaccine dose efficacy and immune response modulation. | Genomics Inform | 2022 | 36239109 | PubTator, text mining | PubMed |
| Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity. | Cells | 2022 | 36231109 | PubTator, text mining | PubMed |
| Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. | Cells | 2022 | 36230990 | PubTator, text mining | PubMed |
| Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung Cancer. | Cancers (Basel) | 2022 | 36230500 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review. | Ann Clin Transl Neurol | 2022 | 36204816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/papers?page=21